CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Whisper Hearing Center

Whisper Hearing Center is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gull Creek Retirement Cmnty

Gull Creek Retirement Cmnty is a Berlin, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tocagen

Tocagen is a clinical stage, biopharmaceutical company pursuing the discovery, development and commercialization of gene therapy products for the treatment of cancer.

PlanVista Corporation

PlanVista Corporation is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AG Mednet

AG Mednet is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.